SCHEMBL9926112

SCHEMBL9926112

O=C([C@@H]1CN(S(=O)(=O)c2cc(Br)c(Br)s2)C[C@H]1c1ccccc1)N1CCN(c2ccccc2F)CC1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.47
LMNA P02545 5/20 0.47
POLB P06746 4/20 0.47
MAPT P10636 1/20 0.47
AR P10275 2/20 0.41
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP2C19 P33261 2/20 0.40
APOBEC3A P31941 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALOX15 P16050 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5264337 1.00 THRB (0.47) THRBLMNAPOLBMAPTAR
SCHEMBL13987571 0.88 MAPT (0.62) LMNAPOLBMAPTALDH1A1SMN1; SMN2
SCHEMBL5266541 0.87 MC4R (0.51) THRBLMNAPOLBMAPTALDH1A1
SCHEMBL5265693 0.87 SMN1; SMN2 (0.52) LMNAPOLBMAPTARALDH1A1
SCHEMBL13987559 0.87 SMN1; SMN2 (0.52) LMNAPOLBMAPTARALDH1A1
SCHEMBL9926050 0.87 MC4R (0.51) THRBLMNAPOLBMAPTALDH1A1
SCHEMBL13987547 0.86 AR (0.46) LMNAPOLBMAPTARALDH1A1
SCHEMBL5265503 0.86 AR (0.46) LMNAPOLBMAPTARALDH1A1
SCHEMBL5264662 0.83 MAPT (0.50) LMNAPOLBMAPTARALDH1A1
SCHEMBL9926066 0.83 MAPT (0.50) LMNAPOLBMAPTARALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836180-B1 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SANOFI SA (FR) 2012-06-13 EP disclosed
US-7468369-B2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs SANOFI-AVENTIS (FR) 2008-12-23 US disclosed
US-20080045540-A1 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045540-A1 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SLC5A1, SLC5A2, KCNJ1 THRB 3442/4885LMNA 3961/4885POLB 4401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.